Takeda Ventures and Astellas Venture Management both backed cell therapy developer Catamaran as it emerged from stealth.

George Washington and Minnesota universities-founded cell therapy developer Catamaran has raised cash to move two assets toward the clinic.

GV is among the investors in the pharmaceutical manufacturing technology startup, which recently secured $750m in series B funding.

Stanford-StartX Fund-backed Subtle Medical produces AI-driven medical imaging software intended to work across systems from various manufacturers.

The Alphabet investment vehicle has helped the online therapist network close a series A round that increased its total funding to $32m.

Maersk Growth helped the food retail software provider increase the size of the round to $25m at a reported $100m valuation.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

MPM Capital and Qiming Venture Partners USA have co-led a series A round for Umoja Biopharma, based on research at Purdue University and Seattle Children’s Research Institute.

Syncona has launched Purespring to commercialise gene therapies aimed at kidney diseases that are based on work at University of Bristol.

NAC International led a series A round for nuclear waste manager Deep Isolation following an initial partnership formed last year.